Study Conduct

ACRES, Ethical to collaborate on eAdjudication

Wednesday, November 25, 2015

Basel, Switzerland-based Ethical, a provider of Centralized Endpoint Adjudication solutions for clinical trials, and the Cambridge, Mass.-based Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector nonprofit organization building a multi-stakeholder-driven integrated global system for clinical research, have partnered to improve Centralized Endpoint Adjudication—an essential element of drug development.

[Read More]

WCG Foundation to offer ethics training, education

Monday, November 23, 2015

Citing the need to provide advanced training and education in research ethics, extend scholarships for an international fellows program and make institutional review board (IRB) reviews more affordable for patients who are desperate to gain access to experimental treatments, WIRB-Copernicus Group has launched the WCG Foundation, a nonprofit public charity, to pursue those three programs.

[Read More]

PharmaSeek launches oncology-based business

Monday, November 23, 2015

PharmaSeek has launched a new business called The Oncology Hub, an initiative to bring together sponsors, CROs, academic research institutions, major medical centers, oncology networks and stand-alone oncology sites in order to assist with site identification for complex clinical trials.

[Read More]

Consortium hopes to make clinical trials more diverse

Sunday, November 15, 2015

Second of two parts

Over the past 20 years, the com­bined efforts of Congress, along with the offices of women’s health at FDA and NIH, have increased the participation of women in clinical tri­als. Minorities, however, still account for less than 5% of clinical trial partici­pants. In fact, minorities “are not hard to reach; they are hardly reached” (Lu Chen, HealthDay News, March 2014).

[Read More]

Parexel, Kyoto ink agreement for Japan’s biopharmaceutical workforce

Friday, November 13, 2015

Parexel International, a global biopharmaceutical services provider, and Kyoto Pharmaceutical University (KPU), a private pharmacy and science university, have announced a new joint program for clinical research and clinical trial management. The academic program offers undergraduate students an accredited, seven-week course designed to prepare them for careers in the biopharmaceutical industry.

[Read More]